Publications by authors named "Eric Bow"

Claim this Profile
L
Low-Efficacy Mu Opioid Agonists as Candidate Analgesics: Effects of Novel C-9 Substituted Phenylmorphans on Pain-Depressed Behavior in Mice.
Edna J Santos, Hamid I Akbarali, Eric W Bow, Dana R Chambers, Eugene S Gutman

J Pharmacol Exp Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies.
Jo-Anne H Young, David R Andes, Monica I Ardura, Antonio Arrieta, Eric J Bow

Open Forum Infect Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates in hematopoietic cell transplant and cellular therapies that enhance the risk for opportunistic infections.
Geoffrey D E Cuvelier, Kristjan Paulson, Eric J Bow

Transpl Infect Dis· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy.
Edna J Santos, Nima Nassehi, Eric W Bow, Dana R Chambers, Eugene S Gutman

Pharmacol Res Perspect· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Impact of the Urgent Cancer Care Clinic on Emergency Department Visits, Primary Care Clinician Visits, and Hospitalizations in Winnipeg, Manitoba.
Katie Galloway, Pascal Lambert, Eric J Bow, Piotr Czaykowski, Tunji Fatoye

Curr Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Potent Highly Biased MOR Partial Agonist among Diastereomeric C9-Hydroxyalkyl-5-phenylmorphans.
Joshua A Lutz, Agnieszka Sulima, Eugene S Gutman, Eric W Bow, Dan Luo

Molecules· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole as an alternative for antifungal prophylaxis in patients with hematological malignancies: Is the signal sufficient to support clinical practice?
Armelle Perez-Cortes Villalobos, Eric J Bow

Transpl Infect Dis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bivalent Conjugate Vaccine Induces Dual Immunogenic Response That Attenuates Heroin and Fentanyl Effects in Mice.
Rodell C Barrientos, Connor Whalen, Oscar B Torres, Agnieszka Sulima, Eric W Bow

Bioconjug Chem· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Dual-Target μ-Opioid Receptor and Dopamine D Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management.
Alessandro Bonifazi, Francisco O Battiti, Julie Sanchez, Saheem A Zaidi, Eric Bow

J Med Chem· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hand Hygiene Compliance at a Canadian provincial cancer centre - the complementary roles of nurse auditor-driven and patient auditor-driven audit processes and impact upon practice in ambulatory cancer care.
Eric J Bow, Venetia Bourrier, David Phillips, Gina Winski, Michele Williams

Am J Infect Control· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Urgent Cancer Care Clinic and Emergency Department Visits for Individuals Diagnosed with Cancer.
Kathleen Decker, Pascal Lambert, Katie Galloway, Oliver Bucher, Marshall Pitz, Eric J Bow

Curr Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel Vaccine That Blunts Fentanyl Effects and Sequesters Ultrapotent Fentanyl Analogues.
Rodell C Barrientos, Eric W Bow, Connor Whalen, Oscar B Torres, Agnieszka Sulima

Mol Pharm· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-Protein biased opioid agonists: 3-hydroxy--phenethyl-5-phenylmorphans with three-carbon chain substituents at C9.
Eugene S Gutman, Eric Bow, Fuying Li, Agnieszka Sulima, Sophia Kaska

RSC Med Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update.
Randy A Taplitz, Erin B Kennedy, Eric J Bow, Jennie Crews, Charise Gleason

J Clin Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update.
Randy A Taplitz, Erin B Kennedy, Eric J Bow, Jennie Crews, Charise Gleason

J Clin Oncol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fungicidal versus fungistatic therapy of invasive infection in non-neutropenic adults: a meta-analysis.
Anand Kumar, Ryan Zarychanski, Amarnath Pisipati, Aseem Kumar, Shravan Kethireddy, Eric J Bow

Mycology· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant.
Carlos Solano, Monica Slavin, Alissa J Shaul, David I Marks, Catherine Cordonnier, Eric J Bow

Mycoses· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation.
Eric W Bow, John M Rimoldi

Perspect Medicin Chem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Johan A Maertens, Issam I Raad, Kieren A Marr, Thomas F Patterson, Dimitrios P Kontoyiannis, Eric J Bow

Lancet· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
Rosemary Barnes, Stephanie Earnshaw, Raoul Herbrecht, Orla Morrissey, Monica Slavin, Eric Bow

Clin Ther· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
Eric J Bow, David J Vanness, Monica Slavin, Catherine Cordonnier, Oliver A Cornely

BMC Infect Dis· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective.
Michel Laverdiere, Eric J Bow, Coleman Rotstein, Julie Autmizguine, Raewyn Broady

Can J Infect Dis Med Microbiol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Kieren A Marr, Haran T Schlamm, Raoul Herbrecht, Scott T Rottinghaus, Eric J Bow

Ann Intern Med· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential consequences of essential drug shortages in Canada: Brain abscess due to Nocardia farcinica associated with dapsone prophylaxis for Pneumocystis jirovecii pneumonia.
Terry C Wuerz, Eric J Bow, Matthew D Seftel

Can J Infect Dis Med Microbiol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection in neutropenic patients with cancer.
Eric J Bow

Crit Care Clin· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis